EU-MEDICAL_DEVICES_REGULATION-ANX_I_SEC_10
EU-MEDICAL_DEVICES_REGULATION-ANX_I_SEC_10
Medical Devices Regulation - Hazardous Substances
EU. Hazardous Substances for Purposes of Medical Devices Regulation 2017/745/EU, 5 May 2017, as amended by Regulation 2020/561/EU, 24 April 2020
This list contains hazardous substances for purposes of the Medical Devices Regulation (MDR), based on the legislation's Annex I general safety and performance requirements, including for chemical, physical and biological properties. Specifically, the non-exhaustive database is derived from: Table 3 of Annex VI to CLP, REACH Candidate List of SVHCs, and Directive 2000/54/EC's Annex III (Biological Agents list).
Last updated 26 april 2024. Database contains 4917 unique substances/entries.
Filter the list
|
231-170-6
|
7440-61-1
|
Acute Tox. 2; STOT RE 2 |
Details | |||
|
show/hide
Uranate(2-), tetrakis(acetato-O)-dioxo-, magnesium (1:1), (OC-6-11)-
EC / List no:
-
| CAS no:
66735-86-2
Calcines, uranium ore-conc.
Calcined precipitates of ammonium, magnesium or sodium uranates obtained from natural uranium ores.
EC / List no:
297-819-0
| CAS no:
93763-02-1
Nickel uranyl tetraacetate, of uranium depleted in uranium-235
EC / List no:
275-994-4
| CAS no:
71767-12-9
Disodium heptaoxodiuranate, of uranium depleted in uranium-235
EC / List no:
237-286-3
| CAS no:
13721-34-1
Tetraammonium uranyl tricarbonate, of uranium depleted in uranium-235
EC / List no:
241-988-5
| CAS no:
18077-77-5
Dipotassium uranyl bis(sulphate), of uranium depleted in uranium-235
EC / List no:
262-284-4
| CAS no:
60542-74-7
Sodium uranyl triacetate, of uranium depleted in uranium-235
EC / List no:
241-714-4
| CAS no:
17712-38-8
Titanate(4-), oxobis[phosphato(3-)]-, barium (1:2), uranium-doped
EC / List no:
309-550-9
| CAS no:
100403-10-9
|
-
|
-
|
Acute Tox. 2; STOT RE 2 |
Details | ||
|
200-123-1
|
51-79-6
|
Carc. 1B |
Details | |||
|
ITC 826 CONCENTRATE
|
422-720-8
|
166242-53-1
|
Carc. 2; Acute Tox. 4; STOT RE 2; Skin Corr. 1B; Skin Sens. 1 |
Details | ||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
Details | |||
|
203-677-2
|
109-52-4
|
Skin Corr. 1B |
Details | |||
|
D,L-VALINEAMIDE
|
402-840-7
|
20108-78-5
|
Repr. 2; Eye Irrit. 2; Skin Sens. 1 |
Details | ||
|
218-894-8
|
2275-23-2
|
Acute Tox. 3; Acute Tox. 4 |
Details | |||
|
424-390-0
|
93280-40-1
|
Acute Tox. 4; STOT RE 2; Eye Dam. 1 |
Details | |||
|
BTN; VPO CATALYST
|
406-260-5
|
58834-75-6
|
Eye Irrit. 2; Skin Sens. 1 |
Details | ||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
Details | |||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
Details | |||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
Details | |||
|
217-681-7
|
1929-77-7
|
Acute Tox. 4 |
Details | |||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
Details | |||
|
-
|
-
|
B Bacteria and similar species |
Details | |||
|
-
|
-
|
B Bacteria and similar species |
Details | |||
|
-
|
-
|
B Bacteria and similar species |
Details | |||
|
256-599-6
|
50471-44-8
|
Carc. 2; Repr. 1B; Skin Sens. 1 |
Details | |||
|
203-545-4
|
108-05-4
|
Flam. Liq. 2; Carc. 2; Acute Tox. 4; STOT SE 3 |
Details | |||
|
200-831-0
|
75-01-4
|
Press. Gas; Flam. Gas 1; Carc. 1A |
Details | |||
|
201-377-6
|
81-81-2
|
Repr. 1A; Acute Tox. 1; Acute Tox. 2; STOT RE 1 |
Details | |||
|
The combination of wastes formed by the coking of bituminous coal tar pitch. It consists predominantly of carbon.
|
295-549-8
|
92062-34-5
|
Carc. 1B |
Details | ||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
Details | |||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
Details | |||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
Details | |||
|
601-810-2
|
12185-10-3
|
Pyr. Sol. 1; Acute Tox. 2; Skin Corr. 1A |
Details | |||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
Details | |||
|
-
|
-
|
P Parasites |
Details | |||
|
607-955-8
|
2655-14-3
|
Acute Tox. 4 |
Details | |||
|
215-535-7
|
1330-20-7
|
Flam. Liq. 3; Acute Tox. 4; Skin Irrit. 2 |
Details | |||
|
215-089-3
|
1300-71-6
|
Acute Tox. 3; Skin Corr. 1B |
Details | |||
|
215-091-4
|
1300-73-8
|
Acute Tox. 3; STOT RE 2 |
Details | |||
|
219-364-9
|
2425-10-7
|
Acute Tox. 4 |
Details | |||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
Details | |||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
Details | |||
|
-
|
-
|
B Bacteria and similar species |
Details | |||
|
-
|
-
|
B Bacteria and similar species |
Details | |||
|
-
|
-
|
B Bacteria and similar species |
Details | |||
|
-
|
-
|
B Bacteria and similar species |
Details | |||
|
Z-6
|
402-280-3
|
149144-82-1
|
Eye Irrit. 2; Skin Irrit. 2 |
Details | ||
|
205-232-8
|
136-23-2
|
Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Skin Sens. 1 |
Details | |||
|
238-270-9
|
14324-55-1
|
Acute Tox. 4; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Skin Sens. 1 |
Details | |||
|
231-592-0
|
7646-85-7
|
Acute Tox. 4; Skin Corr. 1B |
Details | |||
|
show/hide
|
-
|
-
|
Carc. 1A; Acute Tox. 4; Skin Sens. 1 |
Details | ||
|
425-240-7
|
-
|
Eye Dam. 1 |
Details | |||
|
231-175-3
|
7440-66-6
|
Water-react. 1; Pyr. Sol. 1 |
Details | |||
|
231-793-3
|
7733-02-0
|
Acute Tox. 4; Eye Dam. 1 |
Details | |||
|
616-096-8
|
7446-19-7
|
Acute Tox. 4; Eye Dam. 1 |
Details | |||
|
417-130-2
|
1379689-21-0
|
Eye Dam. 1 |
Details | |||